C3853758||Metabolic signatures
C0024032||Lower birthweight
C0243095||increased susceptibility
C0025517||cardiometabolic diseases
C1704259||molecular pathways
C3853758||metabolic profile
C1328813||metabolomics
C0005507||biochemical assays
C0599755||cohorts
C0016132||Finland
C0041700||UK
C0237401||individuals
C0190979||blood sampling
C1305855||body mass index
C1305855||body mass index
C0024032||Lower birthweight
C0005516||biomarkers
C0023820||lipoprotein
C0445604||subclasses
C0015684||fatty acids
C0002520||amino acids
C0005516||markers
C0021368||inflammation
C0086565||impaired liver function
C0599755||cohorts
C3853758||metabolic profiling
C0012727||deviations
C0024032||lower birthweight
C3853758||metabolic signature
C1305855||body mass index
C3853758||metabolic profiling
C0024032||lower birthweight
C1305855||body mass index
C0024032||Lower birthweight
C0005516||biomarker
C3853758||metabolic signatures
C0024032||lower birthweight
C1704259||molecular pathways
C0012727||deviations
C3853758||metabolic risk profile